SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 6-K

                            REPORT OF FOREIGN ISSUER


                      PURSUANT TO RULE 13a-16 or 15d-16 OF
                       THE SECURITIES EXCHANGE ACT OF 1934


                                Dated August 27, 2003

                           REGISTRATION NO. 333-101771

                          GUARDIAN BIOTECHNOLOGIES INC.
                         -------------------------------


                          IPW, 4450 - 110 Gymnasium Place
                     SASKATOON, SASKATCHEWAN, CANADA S7N 0W9
                                (306)-384-4114
                          -------------------------
                    (Address of Principal Executive Offices)


     Indicate by check mark whether the registrant files or will file annual
                 reports under cover of Form 20-F or Form 40-F:

                          Form 20-F: |X| Form 40-F: |_|

     Indicate by check mark if the registrant is submitting the Form 6-K in
              paper as permitted by Regulation S-T Rule 101(b)(1):

                                Yes: |_| No: |X|

     Indicate by check mark if the registrant is submitting the Form 6-K in
              paper as permitted by Regulation S-T Rule 101(b)(7):

                                Yes: |_| No: |X|

         Indicate by check mark whether the registrant by furnishing the
          information contained in this form is also thereby furnishing
          the information to the Commission pursuant to Rule 12g3-2(b)
                   under the Securities Exchange Act of 1934.

                                Yes: |_| No: |X|

       If "Yes" is marked, indicate below the file number assigned to the
          registrant in connection with Rule 12g3-2(b): 82- __________

                                        1


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

GUARDIAN BIOTECHNOLOGIES INC.


Date: August 27, 2003                                            By: /s/ Sun Lee
                                                                   Name: Sun Lee
                                                                Title: President

                                        2


TABLE OF CONTENTS
ITEM 4. Appointment of Independent Auditors

                                        3


ITEM 4.  APPOINTMENT OF INDEPENDENT AUDITORS

Our  Articles  provide  for  the  appointment  by  the  shareholders of Guardian
Biotechnologies  Inc.  of an independent auditor. The independent auditor's term
expires  at  the  close of the ordinary general meeting of shareholders convened
with  respect  to  the  last  fiscal  year  from  the  date of acceptance by the
independent  auditor.

D&H  Group was appointed as an independent auditor of the Company for the fiscal
year  ending  October 31, 2003 by the Board of Directors.  Pannell Kerr Forster,
Chartered  Accountants  served  as  he  Company's  independent  auditor  for the
fiscal  year ending October 31, 2002.  The Company has not had any disagreements
with  Pannell  Kerr  Forster, Chartered Accountants, on any matter of accounting
principle  or  practices,  financial  statement  disclosure or auditing scope or
procedure.

The appointment of D&H Group was approved by the board of directors on August 7,
2003.  D&H  Group  will remain our independent auditor until another independent
auditor  is  appointed  by  the  shareholders  or  until  they  resign from such
position.

                                        4


                                  End of Filing